Eydelman Mikhail

CIK 00019180331 companySAN CARLOS, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001918033

Recent Transactions

50 trades

Exercise/Conversion
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2025-03-05−5,000→ 144,497 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Common Stock
2025-03-05$21.41/sh+5,000→ 46,620 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2025-03-05$72.37/sh−112→ 41,620 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2025-03-05$71.07/sh−2,267→ 41,732 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2025-03-05$70.39/sh−2,621→ 43,999 total
Tax Payment
Vaxcyte, Inc.$PCVX
Common Stock
2025-03-03$72.10/sh−616→ 41,620 total
Tax Payment
Vaxcyte, Inc.$PCVX
Common Stock
2025-02-28$73.02/sh−470→ 42,236 total
Award
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2025-02-27+48,357→ 48,357 total
Award
Vaxcyte, Inc.$PCVX
Common Stock
2025-02-27+14,484→ 42,706 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2025-02-05$87.77/sh−571→ 32,651 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Common Stock
2025-02-05$21.41/sh+5,000→ 33,222 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2025-02-05−5,000→ 149,497 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2025-02-05$91.71/sh−255→ 28,222 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2025-02-05$91.05/sh−1,784→ 28,477 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2025-02-05$89.95/sh−1,755→ 30,261 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2025-02-05$89.09/sh−635→ 32,016 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Common Stock
2025-01-06$21.41/sh+5,000→ 33,222 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2025-01-06$84.86/sh−954→ 32,268 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2025-01-06$85.73/sh−3,921→ 28,347 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2025-01-06−5,000→ 154,497 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2025-01-06$86.52/sh−125→ 28,222 total
Tax Payment
Vaxcyte, Inc.$PCVX
Common Stock
2024-12-09$92.06/sh−475→ 28,222 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2024-12-05$92.90/sh−388→ 28,697 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Common Stock
2024-12-05$21.41/sh+5,000→ 33,697 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2024-12-05$91.91/sh−3,177→ 29,085 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2024-12-05−5,000→ 159,497 total
Gift
Vaxcyte, Inc.$PCVX
Common Stock
2024-12-05−110→ 28,697 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2024-12-05$90.16/sh−1,435→ 32,262 total
Award
Vaxcyte, Inc.$PCVX
Performance Stock Option (right to buy)
2024-11-07+26,125→ 26,125 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2024-11-05−5,000→ 164,497 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2024-11-05$104.80/sh−788→ 32,835 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2024-11-05$105.72/sh−1,415→ 31,420 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Common Stock
2024-11-05$21.41/sh+5,000→ 33,623 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2024-11-05$107.50/sh−1,273→ 28,623 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2024-11-05$106.82/sh−1,524→ 29,896 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2024-10-07$111.68/sh−67→ 28,623 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2024-10-07−5,000→ 169,497 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2024-10-07$109.55/sh−3,147→ 29,004 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2024-10-07$110.50/sh−314→ 28,690 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2024-10-07$108.69/sh−996→ 32,151 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2024-10-07$107.51/sh−476→ 33,147 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Common Stock
2024-10-07$21.41/sh+5,000→ 33,623 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2024-10-01−5,500→ 174,497 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2024-10-01$114.37/sh−3,056→ 29,653 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2024-10-01$115.01/sh−1,030→ 28,623 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Common Stock
2024-10-01$21.41/sh+5,500→ 34,123 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2024-10-01$113.38/sh−1,414→ 32,709 total
Tax Payment
Vaxcyte, Inc.$PCVX
Common Stock
2024-09-03$110.15/sh−2,203→ 28,623 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2024-09-03$107.67/sh−4→ 32,489 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2024-09-03$117.28/sh−80→ 30,826 total

Companies

Vaxcyte, Inc.
SVP, GEN COUNSEL & CORP SEC
$PCVX

Recent Filings

Address

C/O VAXCYTE, INC. 825 INDUSTRIAL ROAD, SUITE 300

SAN CARLOS, CA, 94070

View on SEC.gov